Determination of atorvastatin calcium and its related substances by CZE

Chinese Pharmaceutical Journal

Volumn 38, Issue 6, 2003, Pages 456-458

  Feng, Yu fei ^a   Liu, Zhi he ^a   Wu, Xue jun ^a   Jiang, Wen qing ^a   Zou, Ding ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

Atorvastatin calcium; CZE; Detemination

Indexed keywords

CALCIUM COMPOUNDS; CODES (STANDARDS); ELECTRIC POTENTIAL; ULTRAVIOLET DETECTORS;

PHOSPHATE BUFFERS;

DRUG PRODUCTS;

ATORVASTATIN; BUFFER; PHOSPHATE; SULFACETAMIDE;

ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; ELECTRIC CURRENT; ELECTRIC POTENTIAL; PH; STANDARD; ULTRAVIOLET RADIATION;

EID: 0042591788     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Bullen WW, Miller RA, Hayes RN, et al. Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma[J]. J Am Soc Mass Spectrom, 1999, 10(1):55.
2. Jemal M, Ouyang Z, Chen BC, et al. Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometry [J]. Rapid Commun Mass Spectrom, 1999, 13(11):1003.